Cargando…
Mexican Colorectal Cancer Research Consortium (MEX-CCRC): Etiology, Diagnosis/Prognosis, and Innovative Therapies
In 2013, recognizing that Colorectal Cancer (CRC) is the second leading cause of death by cancer worldwide and that it was a neglected disease increasing rapidly in Mexico, the community of researchers at the Biomedicine Research Unit of the Facultad de Estudios Superiores Iztacala from the Universi...
Autores principales: | , , , , , , , , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9917340/ https://www.ncbi.nlm.nih.gov/pubmed/36768437 http://dx.doi.org/10.3390/ijms24032115 |
_version_ | 1784886342208978944 |
---|---|
author | Andrade-Meza, Antonio Arias-Romero, Luis E. Armas-López, Leonel Ávila-Moreno, Federico Chirino, Yolanda I. Delgado-Buenrostro, Norma L. García-Castillo, Verónica Gutiérrez-Cirlos, Emma B. Juárez-Avelar, Imelda Leon-Cabrera, Sonia Mendoza-Rodríguez, Mónica G. Olguín, Jonadab E. Perez-Lopez, Araceli Pérez-Plasencia, Carlos Reyes, José L. Sánchez-Pérez, Yesennia Terrazas, Luis I. Vaca-Paniagua, Felipe Villamar-Cruz, Olga Rodríguez-Sosa, Miriam |
author_facet | Andrade-Meza, Antonio Arias-Romero, Luis E. Armas-López, Leonel Ávila-Moreno, Federico Chirino, Yolanda I. Delgado-Buenrostro, Norma L. García-Castillo, Verónica Gutiérrez-Cirlos, Emma B. Juárez-Avelar, Imelda Leon-Cabrera, Sonia Mendoza-Rodríguez, Mónica G. Olguín, Jonadab E. Perez-Lopez, Araceli Pérez-Plasencia, Carlos Reyes, José L. Sánchez-Pérez, Yesennia Terrazas, Luis I. Vaca-Paniagua, Felipe Villamar-Cruz, Olga Rodríguez-Sosa, Miriam |
author_sort | Andrade-Meza, Antonio |
collection | PubMed |
description | In 2013, recognizing that Colorectal Cancer (CRC) is the second leading cause of death by cancer worldwide and that it was a neglected disease increasing rapidly in Mexico, the community of researchers at the Biomedicine Research Unit of the Facultad de Estudios Superiores Iztacala from the Universidad Nacional Autónoma de México (UNAM) established an intramural consortium that involves a multidisciplinary group of researchers, technicians, and postgraduate students to contribute to the understanding of this pathology in Mexico. This article is about the work developed by the Mexican Colorectal Cancer Research Consortium (MEX-CCRC): how the Consortium was created, its members, and its short- and long-term goals. Moreover, it is a narrative of the accomplishments of this project. Finally, we reflect on possible strategies against CRC in Mexico and contrast all the data presented with another international strategy to prevent and treat CRC. We believe that the Consortium’s characteristics must be maintained to initiate a national strategy, and the reported data could be useful to establish future collaborations with other countries in Latin America and the world. |
format | Online Article Text |
id | pubmed-9917340 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2023 |
publisher | MDPI |
record_format | MEDLINE/PubMed |
spelling | pubmed-99173402023-02-11 Mexican Colorectal Cancer Research Consortium (MEX-CCRC): Etiology, Diagnosis/Prognosis, and Innovative Therapies Andrade-Meza, Antonio Arias-Romero, Luis E. Armas-López, Leonel Ávila-Moreno, Federico Chirino, Yolanda I. Delgado-Buenrostro, Norma L. García-Castillo, Verónica Gutiérrez-Cirlos, Emma B. Juárez-Avelar, Imelda Leon-Cabrera, Sonia Mendoza-Rodríguez, Mónica G. Olguín, Jonadab E. Perez-Lopez, Araceli Pérez-Plasencia, Carlos Reyes, José L. Sánchez-Pérez, Yesennia Terrazas, Luis I. Vaca-Paniagua, Felipe Villamar-Cruz, Olga Rodríguez-Sosa, Miriam Int J Mol Sci Review In 2013, recognizing that Colorectal Cancer (CRC) is the second leading cause of death by cancer worldwide and that it was a neglected disease increasing rapidly in Mexico, the community of researchers at the Biomedicine Research Unit of the Facultad de Estudios Superiores Iztacala from the Universidad Nacional Autónoma de México (UNAM) established an intramural consortium that involves a multidisciplinary group of researchers, technicians, and postgraduate students to contribute to the understanding of this pathology in Mexico. This article is about the work developed by the Mexican Colorectal Cancer Research Consortium (MEX-CCRC): how the Consortium was created, its members, and its short- and long-term goals. Moreover, it is a narrative of the accomplishments of this project. Finally, we reflect on possible strategies against CRC in Mexico and contrast all the data presented with another international strategy to prevent and treat CRC. We believe that the Consortium’s characteristics must be maintained to initiate a national strategy, and the reported data could be useful to establish future collaborations with other countries in Latin America and the world. MDPI 2023-01-20 /pmc/articles/PMC9917340/ /pubmed/36768437 http://dx.doi.org/10.3390/ijms24032115 Text en © 2023 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/). |
spellingShingle | Review Andrade-Meza, Antonio Arias-Romero, Luis E. Armas-López, Leonel Ávila-Moreno, Federico Chirino, Yolanda I. Delgado-Buenrostro, Norma L. García-Castillo, Verónica Gutiérrez-Cirlos, Emma B. Juárez-Avelar, Imelda Leon-Cabrera, Sonia Mendoza-Rodríguez, Mónica G. Olguín, Jonadab E. Perez-Lopez, Araceli Pérez-Plasencia, Carlos Reyes, José L. Sánchez-Pérez, Yesennia Terrazas, Luis I. Vaca-Paniagua, Felipe Villamar-Cruz, Olga Rodríguez-Sosa, Miriam Mexican Colorectal Cancer Research Consortium (MEX-CCRC): Etiology, Diagnosis/Prognosis, and Innovative Therapies |
title | Mexican Colorectal Cancer Research Consortium (MEX-CCRC): Etiology, Diagnosis/Prognosis, and Innovative Therapies |
title_full | Mexican Colorectal Cancer Research Consortium (MEX-CCRC): Etiology, Diagnosis/Prognosis, and Innovative Therapies |
title_fullStr | Mexican Colorectal Cancer Research Consortium (MEX-CCRC): Etiology, Diagnosis/Prognosis, and Innovative Therapies |
title_full_unstemmed | Mexican Colorectal Cancer Research Consortium (MEX-CCRC): Etiology, Diagnosis/Prognosis, and Innovative Therapies |
title_short | Mexican Colorectal Cancer Research Consortium (MEX-CCRC): Etiology, Diagnosis/Prognosis, and Innovative Therapies |
title_sort | mexican colorectal cancer research consortium (mex-ccrc): etiology, diagnosis/prognosis, and innovative therapies |
topic | Review |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9917340/ https://www.ncbi.nlm.nih.gov/pubmed/36768437 http://dx.doi.org/10.3390/ijms24032115 |
work_keys_str_mv | AT andrademezaantonio mexicancolorectalcancerresearchconsortiummexccrcetiologydiagnosisprognosisandinnovativetherapies AT ariasromeroluise mexicancolorectalcancerresearchconsortiummexccrcetiologydiagnosisprognosisandinnovativetherapies AT armaslopezleonel mexicancolorectalcancerresearchconsortiummexccrcetiologydiagnosisprognosisandinnovativetherapies AT avilamorenofederico mexicancolorectalcancerresearchconsortiummexccrcetiologydiagnosisprognosisandinnovativetherapies AT chirinoyolandai mexicancolorectalcancerresearchconsortiummexccrcetiologydiagnosisprognosisandinnovativetherapies AT delgadobuenrostronormal mexicancolorectalcancerresearchconsortiummexccrcetiologydiagnosisprognosisandinnovativetherapies AT garciacastilloveronica mexicancolorectalcancerresearchconsortiummexccrcetiologydiagnosisprognosisandinnovativetherapies AT gutierrezcirlosemmab mexicancolorectalcancerresearchconsortiummexccrcetiologydiagnosisprognosisandinnovativetherapies AT juarezavelarimelda mexicancolorectalcancerresearchconsortiummexccrcetiologydiagnosisprognosisandinnovativetherapies AT leoncabrerasonia mexicancolorectalcancerresearchconsortiummexccrcetiologydiagnosisprognosisandinnovativetherapies AT mendozarodriguezmonicag mexicancolorectalcancerresearchconsortiummexccrcetiologydiagnosisprognosisandinnovativetherapies AT olguinjonadabe mexicancolorectalcancerresearchconsortiummexccrcetiologydiagnosisprognosisandinnovativetherapies AT perezlopezaraceli mexicancolorectalcancerresearchconsortiummexccrcetiologydiagnosisprognosisandinnovativetherapies AT perezplasenciacarlos mexicancolorectalcancerresearchconsortiummexccrcetiologydiagnosisprognosisandinnovativetherapies AT reyesjosel mexicancolorectalcancerresearchconsortiummexccrcetiologydiagnosisprognosisandinnovativetherapies AT sanchezperezyesennia mexicancolorectalcancerresearchconsortiummexccrcetiologydiagnosisprognosisandinnovativetherapies AT terrazasluisi mexicancolorectalcancerresearchconsortiummexccrcetiologydiagnosisprognosisandinnovativetherapies AT vacapaniaguafelipe mexicancolorectalcancerresearchconsortiummexccrcetiologydiagnosisprognosisandinnovativetherapies AT villamarcruzolga mexicancolorectalcancerresearchconsortiummexccrcetiologydiagnosisprognosisandinnovativetherapies AT rodriguezsosamiriam mexicancolorectalcancerresearchconsortiummexccrcetiologydiagnosisprognosisandinnovativetherapies |